IBD Qorus

Program Overview

Established in 2015 by the Crohn’s and Colitis Foundation, IBD Qorus applies the Institute for Healthcare Improvement (IHI) Breakthrough Series (BTS) collaborative model and a Learning Health System (LHS) approach to engage in a multicenter national improvement collaborative for adult IBD care. Recent Qorus collaborative efforts have focused on reducing unnecessary urgent care utilization and Treat-to-Target— a treatment strategy that aligns a remission-based therapeutic goal with the patient’s personal goals for quality of life. IBD Qorus is lead by co-PI’s Corey Seigel, MD, MS (Dartmouth-Hitchcock) and Gil Melmed, MD (Cedars-Sinai), in collaboration with Alandra Weaver, MPH (Crohn’s and Colitis Foundation), and guided by Brant Oliver, PhD, MS, MPH, FNP-BC, PMHNP-BC (CHIRP, Dartmouth Health), who serves as the IBD Qorus national Improvement Advisor and Improvement Scientist.  Under Dr. Oliver’s direction, a team from the Dartmouth Institute Coproduction Laboratory has developed a quality improvement curriculum and provides improvement coaching support for the collaborative.  Visit the Crohn’s & Colitis Foundation IBD Qorus website to learn more.